loading...| Preferred Name |
quinacrine dihydrochloride |
|
| Synonyms |
atabrine dihydrochloride |
|
| Definitions |
The dihydrochloride salt of the 9-aminoacridine derivative quinacrine with potential antineoplastic and antiparasitic activities. Quinacrine may inhibit the transcription and activity of both basal and inducible nuclear factor-kappaB (NF-kappaB), which may result in the induction of tumor suppressor p53 transcription, the restoration of p53-dependent apoptotic pathways, and tumor cell apoptosis. Continuous NF-kappaB signaling, present in many tumors and in chronic inflammatory processes, promotes the expression of antiapoptotic proteins and cytokines while downregulating the expression of proapoptotic proteins, such as p53. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C67059" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C67059" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000531122 |
|
| altLabel |
atabrine dihydrochloride mepacrine dihydrochoride SN 390 6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine dihydrochloride |
|
| cui |
C0282331 C0949411 |
|
| DATE FIRST PUBLISHED |
2007-01-19 |
|
| Date last modified |
2008-04-22 |
|
| definition |
The dihydrochloride salt of the 9-aminoacridine derivative quinacrine with potential antineoplastic and antiparasitic activities. Quinacrine may inhibit the transcription and activity of both basal and inducible nuclear factor-kappaB (NF-kappaB), which may result in the induction of tumor suppressor p53 transcription, the restoration of p53-dependent apoptotic pathways, and tumor cell apoptosis. Continuous NF-kappaB signaling, present in many tumors and in chronic inflammatory processes, promotes the expression of antiapoptotic proteins and cytokines while downregulating the expression of proapoptotic proteins, such as p53. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C67059" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C67059" NCI Thesaurus) |
|
| NCI ID |
C67059 |
|
| notation |
CDR0000531122 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
quinacrine dihydrochloride |
|
| tui |
T109 T121 |